By Modupe Gbadeyanka
Mrs Ebere lgboko Ekpunobi has resigned as the Managing Director/CEO of Neimeth International Pharmaceuticals Plc.
This information was revealed by the firm yesterday in a notice to the Nigerian Stock Exchange (NSE) and signed by its scribe, Mrs F. I. Onyenekwe.
It was disclosed that Mrs Ekpunobi’s resignation has been accepted by the Board of Directors of Neimeth International Pharmaceuticals Plc.
It was explained that Mrs Ekpunobi, who joined Neimeth International Pharmaceuticals Plc in November 2015 as Acting Managing Director and was confirmed to the position in March 2016, suffered a sporting accident on May 18, 2017, and had to travel overseas for medication which is still on-going and has necessitated her resignation on September 11, 2017.
“The Board wishes her God’s complete healing and success in her future endeavours,” the statement said.
In view of this development, the board has announced the appointment of Mr Chris Mmeje as the Acting Managing Director/CEO of the pharmaceutical firm with immediate effect.
Mr Mmeje has been the Finance Director of the company since 2008 and prior to that, he had distinguished career in the banking industry that spanned over 25 years. He will oversee the affairs of the company until the emergence of a substantive Managing Director.
Adedapo Adesanya 
Aduragbemi Omiyale